Advertisement
Screener

IBOTTA, INC. (IBTA) Research and Development Expense

2.8 / 5 stars · 68/120 Roast Me

IBOTTA, INC. Research and Development Expense

IBOTTA, INC. (IBTA) reported Research and Development Expense of $15.07 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.

Financial Statements › Expense Statement › Operating Expenses

us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-04

  • IBOTTA, INC. research and development expense for the quarter ending 2026-06-30 was $15.07M, a 2.22% increase year-over-year.
  • IBOTTA, INC. research and development expense for the quarter ending 2026-03-31 was $14.50M, a 19.74% decline year-over-year.
  • IBOTTA, INC. research and development expense for the quarter ending 2025-12-31 was $14.25M, a 9.94% decline year-over-year.
  • IBOTTA, INC. research and development expense for the quarter ending 2025-09-30 was $14.02M, a 13.90% decline year-over-year.
  • IBOTTA, INC. research and development expense for fiscal 2025 was $61.08M, a 3.46% decline from fiscal 2024.
  • IBOTTA, INC. research and development expense for fiscal 2024 was $63.27M, a 26.55% increase from fiscal 2023.
  • IBOTTA, INC. research and development expense for fiscal 2023 was $50.00M, a 17.48% increase from fiscal 2022.
  • IBOTTA, INC. research and development expense for fiscal 2022 was $42.56M.
Period endResearch and Development Expense 3 monthResearch and Development Expense 6 monthResearch and Development Expense 9 monthResearch and Development Expense 12 month
2026-06-30$15.07M
10-Q · filed 2026-08-04
$29.57M
10-Q · filed 2026-08-04
$43.82M
derived: sum of 3 quarters · filed 2026-08-04
$57.84M
derived: sum of 4 quarters · filed 2026-08-04
2026-03-31$14.50M
10-Q · filed 2026-05-06
$28.75M
derived: sum of 2 quarters · filed 2026-05-06
$42.77M
derived: sum of 3 quarters · filed 2026-05-06
$57.52M
derived: sum of 4 quarters · filed 2026-08-04
2025-12-31$14.25M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$28.27M
derived: sum of 2 quarters · filed 2026-02-26
$43.01M
derived: sum of 3 quarters · filed 2026-08-04
$61.08M
10-K · filed 2026-02-26
2025-09-30$14.02M
10-Q · filed 2025-11-13
$28.77M
derived: sum of 2 quarters · filed 2026-08-04
$46.84M
10-Q · filed 2025-11-13
$62.66M
derived: sum of 4 quarters · filed 2026-08-04
2025-06-30$14.74M
10-Q · filed 2026-08-04
$32.81M
10-Q · filed 2026-08-04
$48.63M
derived: sum of 3 quarters · filed 2026-08-04
$64.92M
derived: sum of 4 quarters · filed 2026-08-04
2025-03-31$18.07M
10-Q · filed 2026-05-06
$33.89M
derived: sum of 2 quarters · filed 2026-05-06
$50.17M
derived: sum of 3 quarters · filed 2026-05-06
$67.70M
derived: sum of 4 quarters · filed 2026-05-06
2024-12-31$15.82M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$32.10M
derived: sum of 2 quarters · filed 2026-02-26
$49.63M
derived: sum of 3 quarters · filed 2026-02-26
$63.27M
10-K · filed 2026-02-26
2024-09-30$16.29M
10-Q · filed 2025-11-13
$33.81M
derived: sum of 2 quarters · filed 2025-11-13
$47.45M
10-Q · filed 2025-11-13
$61.14M
derived: sum of 4 quarters · filed 2026-02-26
2024-06-30$17.53M
10-Q · filed 2025-08-13
$31.17M
10-Q · filed 2025-08-13
$44.86M
derived: sum of 3 quarters · filed 2026-02-26
$57.25M
derived: sum of 4 quarters · filed 2026-02-26
2024-03-31$13.64M
10-Q · filed 2025-05-15
$27.33M
derived: sum of 2 quarters · filed 2026-02-26
$39.72M
derived: sum of 3 quarters · filed 2026-02-26
$51.94M
derived: sum of 4 quarters · filed 2026-02-26
2023-12-31$13.69M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$26.08M
derived: sum of 2 quarters · filed 2026-02-26
$38.30M
derived: sum of 3 quarters · filed 2026-02-26
$50.00M
10-K · filed 2026-02-26
2023-09-30$12.39M
10-Q · filed 2024-11-14
$24.61M
derived: sum of 2 quarters · filed 2024-11-14
$36.31M
10-Q · filed 2024-11-14
2023-06-30$12.22M
10-Q · filed 2024-08-14
$23.91M
10-Q · filed 2024-08-14
2023-03-31$11.70M
10-Q · filed 2024-05-31
2022-12-31$42.56M
10-K · filed 2025-02-27